5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors. [electronic resource]
Producer: 20100826Description: 1166-78 p. digitalISSN:- 1097-0045
- Androgen Antagonists -- administration & dosage
- Androgen Receptor Antagonists
- Anilides -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Azacitidine -- administration & dosage
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Drug Synergism
- Humans
- Male
- Mice
- Mice, Nude
- Neoplasms, Experimental
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- administration & dosage
- Prostatic Neoplasms -- drug therapy
- Random Allocation
- Receptors, Androgen -- biosynthesis
- Tosyl Compounds -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.